News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
729,547 Results
Type
Article (59209)
Company Profile (640)
Press Release (669698)
Multimedia
Podcasts (94)
Webinars (14)
Section
Business (203373)
Career Advice (3067)
Deals (36148)
Drug Delivery (126)
Drug Development (83497)
Employer Resources (182)
FDA (17262)
Job Trends (15754)
News (350526)
Policy (35204)
Tag
Academia (2978)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (96)
Alliances (52877)
ALS (106)
Alzheimer's disease (1497)
Antibody-drug conjugate (ADC) (159)
Approvals (17224)
Artificial intelligence (305)
Autoimmune disease (28)
Automation (17)
Bankruptcy (374)
Best Places to Work (12410)
BIOSECURE Act (21)
Biosimilars (119)
Biotechnology (437)
Bladder cancer (85)
Brain cancer (30)
Breast cancer (312)
Cancer (2470)
Cardiovascular disease (205)
Career advice (2577)
Career pathing (34)
CAR-T (177)
Cell therapy (480)
Cervical cancer (22)
Clinical research (67485)
Collaboration (935)
Company closure (2)
Compensation (508)
Complete response letters (29)
COVID-19 (2843)
CRISPR (50)
C-suite (269)
Cystic fibrosis (110)
Data (2380)
Decentralized trials (2)
Denatured (33)
Depression (55)
Diabetes (298)
Diagnostics (6853)
Digital health (20)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (133)
Drug pricing (131)
Drug shortages (32)
Duchenne muscular dystrophy (103)
Earnings (80531)
Editorial (44)
Employer branding (23)
Employer resources (157)
Events (109979)
Executive appointments (789)
FDA (18700)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (819)
Gene editing (124)
Generative AI (27)
Gene therapy (356)
GLP-1 (841)
Government (4992)
Grass and pollen (6)
Guidances (158)
Healthcare (20473)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (148)
Indications (30)
Infectious disease (3006)
Inflammatory bowel disease (158)
Inflation Reduction Act (11)
Influenza (58)
Intellectual property (103)
Interviews (574)
IPO (16828)
IRA (49)
Job creations (3814)
Job search strategy (2137)
Kidney cancer (11)
Labor market (42)
Layoffs (535)
Leadership (24)
Legal (8244)
Liver cancer (82)
Lung cancer (349)
Lymphoma (161)
Machine learning (9)
Management (62)
Manufacturing (363)
MASH (83)
Medical device (14305)
Medtech (14310)
Mergers & acquisitions (19908)
Metabolic disorders (797)
Multiple sclerosis (90)
NASH (22)
Neurodegenerative disease (117)
Neuropsychiatric disorders (33)
Neuroscience (2111)
NextGen: Class of 2025 (7334)
Non-profit (5028)
Now hiring (39)
Obesity (428)
Opinion (268)
Ovarian cancer (83)
Pain (102)
Pancreatic cancer (91)
Parkinson's disease (164)
Partnered (24)
Patents (261)
Patient recruitment (119)
Peanut (51)
People (58296)
Pharmaceutical (132)
Pharmacy benefit managers (22)
Phase I (21018)
Phase II (29641)
Phase III (22390)
Pipeline (1414)
Policy (174)
Postmarket research (2628)
Preclinical (9180)
Press Release (71)
Prostate cancer (115)
Psychedelics (34)
Radiopharmaceuticals (269)
Rare diseases (434)
Real estate (6397)
Recruiting (72)
Regulatory (24323)
Reports (45)
Research institute (2625)
Resumes & cover letters (489)
Rett syndrome (6)
RNA editing (5)
RSV (49)
Schizophrenia (80)
Series A (141)
Series B (93)
Service/supplier (27)
Sickle cell disease (58)
Special edition (19)
Spinal muscular atrophy (160)
Sponsored (34)
Startups (3775)
State (2)
Stomach cancer (15)
Supply chain (76)
Tariffs (56)
The Weekly (59)
Vaccines (814)
Venture capitalists (42)
Weight loss (299)
Women's health (36)
Worklife (20)
Date
Today (186)
Last 7 days (998)
Last 30 days (3217)
Last 365 days (34122)
2025 (12345)
2024 (36963)
2023 (41731)
2022 (53089)
2021 (57728)
2020 (56775)
2019 (50380)
2018 (38347)
2017 (34962)
2016 (34274)
2015 (39676)
2014 (31804)
2013 (27425)
2012 (29486)
2011 (29902)
2010 (27342)
Location
Africa (953)
Alabama (61)
Alaska (7)
Arizona (218)
Arkansas (14)
Asia (44258)
Australia (7877)
California (6505)
Canada (2097)
China (577)
Colorado (288)
Connecticut (300)
Delaware (167)
Europe (99207)
Florida (964)
Georgia (229)
Hawaii (1)
Idaho (60)
Illinois (605)
India (29)
Indiana (345)
Iowa (12)
Japan (175)
Kansas (111)
Kentucky (28)
Louisiana (14)
Maine (71)
Maryland (966)
Massachusetts (4890)
Michigan (250)
Minnesota (412)
Mississippi (2)
Missouri (91)
Montana (31)
Nebraska (25)
Nevada (70)
New Hampshire (66)
New Jersey (1827)
New Mexico (31)
New York (1841)
North Carolina (1138)
North Dakota (9)
Northern California (2780)
Ohio (226)
Oklahoma (15)
Oregon (46)
Pennsylvania (1429)
Puerto Rico (14)
Rhode Island (35)
South America (1334)
South Carolina (26)
South Dakota (1)
Southern California (2419)
Tennessee (107)
Texas (980)
United States (24803)
Utah (198)
Virginia (174)
Washington D.C. (70)
Washington State (598)
West Virginia (3)
Wisconsin (70)
729,547 Results for "pro medicus limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd. for ~US$75 Million in a Share Exchange Transaction
Antev Shareholders to Receive Aggregate ~19% Equity Stake in Medicus, Plus US$65 Million in Contingent Payments
April 28, 2025
·
10 min read
Press Releases
Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)
April 21, 2025
·
7 min read
Press Releases
Medicus Pharma Ltd. Announces Closing of $4.2 Million Regulation A Offering
March 10, 2025
·
5 min read
Press Releases
Medicus Pharma Ltd. Announces Pricing of $4.2 Million Regulation A Offering
March 7, 2025
·
5 min read
Press Releases
Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)
February 14, 2025
·
5 min read
Earnings
Amgen Advocates For ‘Pro-Growth Tax Policy’ Instead of Tariffs to Boost Domestic Manufacturing
Like fellow Big Pharmas Eli Lilly and Johnson & Johnson, Amgen is urging the Trump administration to consider tax policy instead of tariffs to promote domestic pharma manufacturing.
May 2, 2025
·
2 min read
·
Tristan Manalac
Imbiotechnologies Signs Supply Agreement With Medicus Management
IMBiotechnologies Ltd. is pleased to announce the signing of a supply agreement with Medicus Management, LLC, a group purchasing organization currently supplying twenty office-based laboratory and ambulatory surgical center clinics focused on minimally-invasive procedures.
June 12, 2024
·
2 min read
Press Releases
Medicus Pharma Ltd. Enters into Standby Equity Purchase Agreement and Announces Intention to Voluntarily Delist from the TSX Venture Exchange (TSXV)
February 11, 2025
·
6 min read
Press Releases
AtriCure Announces First Use of the AtriClip PRO-Mini® Device
April 10, 2025
·
5 min read
Press Releases
Nordic Bioscience announces PRO-C3 launched by Roche Diagnostics on cobas analysers
May 8, 2025
·
2 min read
1 of 72,955
Next
